Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

Moderator

John H. Stone, MD, MPH

Professor of Medicine
Harvard Medical School
The Edward A. Fox Chair in Medicine
Massachusetts General Hospital
Boston, Massachusetts

Disclosures

John H Stone, MD, MPH, has the following relevant financial relationships:
Consultant or advisor for: Bristol Myers Squibb; ChemoCentryx, Inc.; Horizon; Sanofi
Research funding from: Bristol Myers Squibb; Horizon; Sanofi

Faculty

Ulrich Specks, MD

Connor Group Foundation Professor of Medicine
Division of Pulmonary and Critical Care Medicine
Mayo Clinic College of Medicine and Sciences
Rochester, Minnesota

Disclosures

Ulrich Specks, MD, has the following relevant financial relationships:
Consultant or advisor for: AstraZeneca; Boehringer Ingelheim Pharmaceuticals, Inc.; ChemoCentryx, Inc.
Research funding from: AstraZeneca; Bristol Myers Squibb; Genentech; GlaxoSmithKline
Owns stock (publicly traded) in: AbbVie; Johnson and Johnson; Pfizer

Editor

Karen Badal, MD, MPH

Senior Medical Education Director, Medscape, LLC

Disclosures

Karen Badal, MD, MPH, has no relevant financial relationships.

Compliance Reviewer

Lisa Simani, APRN, MS, ACNP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Lisa Simani, APRN, MS, ACNP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.

CME

The Balancing Act: A Clinical Conversation on Treating ANCA-Associated Vasculitis

Authors: John H. Stone, MD, MPH; Ulrich Specks, MD
CME Released: 12/27/2022
Valid for credit through: 12/27/2023, 11:59 PM EST

Start Activity

Credits Available

Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

You Are Eligible For
- Letter of Completion

Target Audience and Goal Statement

This activity is intended for rheumatologists, nephrologists, pulmonologists, and other healthcare providers (HCPs) who provide care to patients with AAV.

The goal of this activity is that learners will be better able to interpret and apply recent clinical data on AAV therapies and management to their own clinical practice after completing this activity.

Upon completion of this activity, participants will:

Have increased knowledge regarding the
- Clinical data on new treatments for AAV
Have greater competence related to
- Selecting induction therapy to achieve remission in patients with AAV
- Assessing risk of glucocorticoid toxicity in patients with AAV
Demonstrate greater confidence in their ability to
- Reduce the risk of glucocorticoid toxicity

Disclosures

Moderator

John H. Stone, MD, MPH

Professor of Medicine
Harvard Medical School
The Edward A. Fox Chair in Medicine
Massachusetts General Hospital
Boston, Massachusetts

Disclosures

John H Stone, MD, MPH, has the following relevant financial relationships:
Consultant or advisor for: Bristol Myers Squibb; ChemoCentryx, Inc.; Horizon; Sanofi
Research funding from: Bristol Myers Squibb; Horizon; Sanofi

Faculty

Ulrich Specks, MD

Connor Group Foundation Professor of Medicine
Division of Pulmonary and Critical Care Medicine
Mayo Clinic College of Medicine and Sciences
Rochester, Minnesota

Disclosures

Ulrich Specks, MD, has the following relevant financial relationships:
Consultant or advisor for: AstraZeneca; Boehringer Ingelheim Pharmaceuticals, Inc.; ChemoCentryx, Inc.
Research funding from: AstraZeneca; Bristol Myers Squibb; Genentech; GlaxoSmithKline
Owns stock (publicly traded) in: AbbVie; Johnson and Johnson; Pfizer

Editor

Karen Badal, MD, MPH

Senior Medical Education Director, Medscape, LLC

Disclosures

Karen Badal, MD, MPH, has no relevant financial relationships.

Compliance Reviewer

Lisa Simani, APRN, MS, ACNP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Lisa Simani, APRN, MS, ACNP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.

Accreditation Statements

Developed through a partnership between Medscape Education and The American College of Rheumatology.

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For Physicians

Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

Read about the target audience, learning objectives, and author disclosures.
Study the educational content online or print it out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

From Medscape Education Infectious Diseases

CME

The Balancing Act: A Clinical Conversation on Treating ANCA-Associated Vasculitis

Authors: John H. Stone, MD, MPH; Ulrich Specks, MDFaculty and Disclosures

CME Released: 12/27/2022

Valid for credit through: 12/27/2023, 11:59 PM EST

processing....

Educational Impact Challenge

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.

Page 1 of 4

CME Information Download Slides

Activity Transcript

Print
Like Tweet

Activity Transcript

Disclaimer

The educational activity presented above may involve simulated, case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient, whether living or deceased, is intended or should be inferred.

The material presented here does not necessarily reflect the views of Medscape, LLC, or any individuals or commercial entities that support companies that support educational programming on medscape.org. These materials may include discussion of therapeutic products that have not been approved by the US Food and Drug Administration, off-label uses of approved products, or data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal. Readers should verify all information and data before treating patients or employing any therapies described in this or any educational activity. A qualified healthcare professional should be consulted before using any therapeutic product discussed herein.

Faculty and Disclosures

Moderator

John H. Stone, MD, MPH

Faculty

Ulrich Specks, MD

Editor

Karen Badal, MD, MPH

Compliance Reviewer

Lisa Simani, APRN, MS, ACNP

Peer Reviewer

CME

The Balancing Act: A Clinical Conversation on Treating ANCA-Associated Vasculitis

Credits Available

You Are Eligible For

Target Audience and Goal Statement

Disclosures

Moderator

John H. Stone, MD, MPH

Faculty

Ulrich Specks, MD

Editor

Karen Badal, MD, MPH

Compliance Reviewer

Lisa Simani, APRN, MS, ACNP

Peer Reviewer

Accreditation Statements

For Physicians

Instructions for Participation and Credit

The Balancing Act: A Clinical Conversation on Treating ANCA-Associated Vasculitis

Educational Impact Challenge